AlphaCrest Capital Management’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
2022
Q3
$738K Sell
2022
Q2
$1.84M Buy
2022
Q1
$580K Sell
2021
Q4
$1.95M Buy
2021
Q3
$1.23M Buy
2021
Q2
$735K Sell
2021
Q1
$1.03M Buy
2020
Q4
Sell
2020
Q3
$256K Sell
2020
Q2
$314K Sell
2020
Q1
$694K Buy
2019
Q4
$371K Sell
2019
Q3
$1.29M Buy
2019
Q2
$708K Buy